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Reply to Lawn and Wood
To the Editor—Lawn and Wood [1] raise
an important issue concerning the rela-
tionship between CD4 cell counts and
mortality in people infected with HIV and
note that there is substantial variation in
CD4 cell counts at death. As CD4 cell
counts decline, the incidence of oppor-
tunistic infections increases monotonically
[2]; if such infections are left untreated,
then people may die when their CD4 cell
counts are still relatively high, just as an
HIV-negative person might. For example,
in a comparison of 8 studies, the mean
CD4 cell count in HIV-positive patients
presenting with tuberculosis was 202 cells/
mL (range, 136–269 cells/mL) [3]. If better
data on the time course of CD4 cell counts
in a sufficiently large sample of HIV-pos-
itive patients were available, more-sophis-
ticated models of the relationship between
CD4 cell count decline, the incidence of
opportunistic infections, and mortality
could be developed. Our model, which
draws on the limited data that are cur-
rently available, is a step in this direction.
It is nevertheless worth noting that
evidence from industrialized as well as
low- and middle-income countries suggests
that the majority of AIDS-related deaths
occur at very low CD4 cell counts. For
example, in a study in South Africa in the
early 1990s, the median CD4 cell count at
the onset of AIDS was 98 cells/mL for het-
erosexual patients and 40 cells/mL for ho-
mosexual patients, after which the median
survival time was 17 and 7 months, re-
spectively [4]. In an Australian cohort fol-
lowed between 1986 and 1991, the median
CD4 cell count at death was 10 cells/mL
[5]. In Uganda, a recent study showed that
the median CD4 cell count at death was
24 cells/mL [6]. In the United Kingdom, a
study reported mean CD4 cell counts at
death of 19 cells/mL in 1988, 44 cells/mL
in 1997, and 58 cells/mL in 1998 [7].
For the purpose of our model, the var-
iation in CD4 cell counts at death is less
important than the variation in and level
of CD4 cell counts before HIV serocon-
version, which appear to affect the rate of
CD4 cell count decline and, hence, the
survival time after infection. A recent
study compared CD4 cell counts in HIV-
negative persons from 7 countries, and the
medians varied from 599 cells/mL in Bo-
tswana to 968 cells/mL in Tanzania [8]; the
authors suggested that CD4 cell count ref-
erence ranges should be established for
local populations, given the pivotal role
played by CD4 cell counts in decision
making on the initiation and monitoring
of highly active antiretroviral therapy.
The most important prediction of our
model is that the distribution of survival
times is independent of the initial CD4
cell count, and this prediction is not sub-
stantively altered if we assume a somewhat
higher CD4 cell count at death. To the
extent that the prediction is true, it sug-
gests that, for a given person or group of
people, survival from a given CD4 cell
count will be longer for those whose initial
CD4 cell count is low than for those in
whom it is high. More-extensive data and
more-sophisticated models could provide
important insights into the relationship
among CD4 cell count, the progression of
HIV infection, and mortality, as Lawn and
Wood suggest.
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